(Q37977140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Gary Benson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Günter Auerswald

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ivo Elezović

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Thierry Lambert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Rolf Ljung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Massimo Morfini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Silva Zupančić Salek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

1 reference

7 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Haematology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

371-379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

International workshop on immune tolerance induction: consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

European study on orthopaedic status of haemophilia patients with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Immunoadsorption for removal of inhibitors: update on treatments in Malmö-Lund between 1980 and 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Immune tolerance for the treatment of factor VIII inhibitors--twenty years' 'bonn protocol'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Tolerance induction using the Malmö treatment model 1982-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn Protocol': predictive parameter for therapy duration and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Factor IX inhibitors and anaphylaxis in hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

The international immune tolerance study: a multicenter prospective randomized trial in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Prophylaxis in haemophilia with inhibitors: update from international experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

21 January 2018

Male gonadal toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Inhibitor treatment in haemophilias A and B: inhibitor diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Immune tolerance induction in hemophilia A: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Immune tolerance induction: recombinant vs. human-derived product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Role of von Willebrand factor in immune tolerance induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

VWF/FVIII concentrates in high-risk immunotolerance: the RESIST study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01754.X

10.1111/J.1600-0609.2012.01754.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260405%20AND%20SRC:MED&resulttype=core&format=json